Sahajanand Medical Technologies - Dose Daily : Pharma News | Latest Pharmaceutical News, Research & Updates

Dose Daily News is your trusted source for the latest updates in healthcare and pharmaceuticals. We deliver clear, reliable, and timely news to keep you informed and ahead in the world of health and medicine.

Latest news

Sahajanand Medical Technologies Secures Health Canada Class IV Licence for Supraflex Cruz™️ Stent System, Entering Canadian Market

Breaking News September 12, 2026 0

Sahajanand Medical Technologies (SMT), a leading global medical device...

Lundbeck Receives U.S. FDA Orphan Drug Designation for Investigational Therapy in Endogenous Cushing’s Syndrome

Breaking News September 12, 2026 0

H. Lundbeck A/S (Lundbeck) announced that the U.S. Food and Drug...

U.S. FDA Grants Accelerated Approval for Bayer’s Sevabertinib as First-Line Therapy in Advanced HER2-Mutant NSCLC Following 75% Response Rate

Breaking News September 12, 2026 0

Bayer announced that the U.S. Food and Drug Administration...

Lundbeck Receives U.S. FDA Orphan Drug Designation for Investigational Therapy in Endogenous Cushing’s Syndrome

Breaking News September 12, 2026 0

H. Lundbeck A/S (Lundbeck) announced that the U.S. Food and Drug...

DCGI Issues All-India Alert Over Counterfeit Abhayrab Vaccine Batch Following Failed CDL Kasauli Tests

Breaking News September 7, 2026 0

Drug regulatory bodies and law enforcement agencies have intensified...

Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia

Breaking News September 10, 2026 0

Johnson & Johnson announced the presentation of comprehensive new...

Tag: Sahajanand Medical Technologies

Lundbeck Receives U.S. FDA Orphan Drug Designation for Investigational Therapy in Endogenous Cushing’s Syndrome

U.S. FDA Grants Accelerated Approval for Bayer’s Sevabertinib as First-Line Therapy in Advanced HER2-Mutant NSCLC Following 75% Response Rate

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Follow us

Categories

Latest news

Sahajanand Medical Technologies Secures Health Canada Class IV Licence for Supraflex Cruz™️ Stent System, Entering Canadian Market

Lundbeck Receives U.S. FDA Orphan Drug Designation for Investigational Therapy in Endogenous Cushing’s Syndrome

U.S. FDA Grants Accelerated Approval for Bayer’s Sevabertinib as First-Line Therapy in Advanced HER2-Mutant NSCLC Following 75% Response Rate

Popular news

Lundbeck Receives U.S. FDA Orphan Drug Designation for Investigational Therapy in Endogenous Cushing’s Syndrome

DCGI Issues All-India Alert Over Counterfeit Abhayrab Vaccine Batch Following Failed CDL Kasauli Tests

Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia